 |
16 Products |  |
56 Diseases | | 16 Products |
|
39 Trials |  |
939 News |  |
| «12...234567891011121314 |
- | ASP7317 / Octapharma, CHA Bio & Diostech, Astellas
New P1/2 trial, Metastases: A Phase I/IIa, Open-Label, Single-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial(MA09-hRPE) Cells in Patients With Advanced Dry Age-related Macular Degeneration(AMD) (clinicaltrials.gov) - Aug 27, 2012
P1/2, N=12, Recruiting, Sponsor: CHA Bio & Diostech
- ||||||| Panzyga (human immune globulin intravenous 10% stabilised with glycine) / Octapharma
Trial completion: A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases (clinicaltrials.gov) - Aug 23, 2012
P3, N=51, Completed, Sponsor: Octapharma
Active, not recruiting --> Completed
- ASP7317 / Octapharma, CHA Bio & Diostech, Astellas
New P1 trial: Safety and Tolerability of MA09-hRPE Cells in Patients With Stargardt's Macular Dystrophy(SMD) (clinicaltrials.gov) - Jun 19, 2012
P1, N=3, Recruiting, Sponsor: CHA Bio & Diostech
- | Fibryga (fibrinogen concentrate (human)) / Octapharma
New P2 trial: Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap (clinicaltrials.gov) - Apr 9, 2012
P2, N=18, Recruiting, Sponsor: Octapharma
- || Nuwiq (simoctocog alfa) / Octapharma
Trial completion: Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A (clinicaltrials.gov) - Feb 21, 2012
P3, N=32, Completed, Sponsor: Octapharma
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | ASP7317 / Octapharma, CHA Bio & Diostech, Astellas
New P1/2 trial: Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD) (clinicaltrials.gov) - Nov 8, 2011
P1/2, N=16, Recruiting, Sponsor: Advanced Cell Technology
- ||||| Balfaxar (prothrombin complex concentrate, human-lans) / Octapharma, Pfizer
Enrollment change, Surgery: Study of Octaplex (Human Prothrombin Complex Concentrate) and Fresh Frozen Plasma in Patients Under Vitamin K Therapy Antagonist Needing Urgent Surgery or Invasive Procedures (clinicaltrials.gov) - Nov 7, 2011
P3, N=200, Completed, Sponsor: Octapharma
Active, not recruiting --> Completed N=164 --> 200
- | Wilate (human factor VIII/von Willebrand factor) / Octapharma
Enrollment open, Surgery: WONDERS: Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery (clinicaltrials.gov) - Sep 26, 2011
P3, N=41, Recruiting, Sponsor: Octapharma
N=164 --> 200 Not yet recruiting --> Recruiting
- ||| Nuwiq (simoctocog alfa) / Octapharma
New P3 trial: Follow-Up study in Previously Treated Children to investigate a new FVIII concentrate (EUDRACT) - Aug 7, 2011
P3, N=20, Ongoing, Sponsor: Octapharma AG